The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Cohen, Ezra
Item TypeName
Concept Immunotherapy
Academic Article Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.
Academic Article Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.
Academic Article Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics.
Academic Article A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy.
Academic Article The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
Academic Article Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study.
Academic Article Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.
Academic Article Role of B Cells in Responses to Checkpoint Blockade Immunotherapy and Overall Survival of Cancer Patients.
Academic Article Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities.
Academic Article Inevitable Progress-Relying on the Immune System, Not Chance.
Academic Article Patient selection for immunotherapy in head and neck cancer - Authors' reply.
Grant Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
Grant Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC
Grant A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
Academic Article Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy.
Academic Article Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.
Academic Article Facts and Hopes in Neoadjuvant Immunotherapy: Current Approvals and Emerging Evidence.
Academic Article Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial.
Search Criteria
  • Immunotherapy